Symptomatic Treatment of Vascular Cognitive Impairment

NCT02098824 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment (Vascular)
Mild Cognitive Disorder (Vascular)
Vascular Dementia

Interventions

DRUG: Galantamine
DRUG: Methylphenidate
DRUG: Placebo

Sponsor

Amsterdam UMC, location VUmc